Search for: "Hoffmann-La Roche" Results 41 - 60 of 180
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
23 Feb 2016, 1:53 am
Hoffmann-La Roche AG and Genentech Inc. [read post]
17 Feb 2016, 12:19 am
Hoffmann-La Roche AG and Genentech Inc. [2016] EWHC 188 (Pat) come across her desk a few weeks ago. [read post]
11 Feb 2015, 12:23 pm
Bayer’s predecessor, Hoffmann-La Roche, filed a US application for FLANAX in February 2004. [read post]
12 Dec 2014, 5:06 am
My post on Wednesday morning has attracted a large number of comments, including many thoughtful contributions, and so I would like to follow up concerning the wider issue of product-by-process claims (independent of the specific Hospira v Genentech case), gathering up, and responding to, some of the comments.In the meantime, readers interested in the decision itself may care to visit the report by Katfriend Suleman Ali (Holly IP) posted on the PatLit blog here, which has a more detailed analysis of… [read post]
12 Apr 2014, 6:39 am by Lawrence B. Ebert
Hoffman-LaRoche and Genentech cases on BonivaHoffman-LaRoche lost its appeal at the CAFC:Plaintiff Hoffmann-La Roche, Inc., (“Roche”) appealsfrom the decision of the United States District Court forthe District of New Jersey granting the defendant genericdrug companies summary judgment of invalidity as toclaims 1-8 of U.S. [read post]
19 Mar 2014, 9:00 am by Paula Bremner
It has been 15 years since the last brand v brand challenge of a biologic patent in Canada. [read post]
27 Feb 2014, 9:38 am by Dennis Crouch
Cir. 2009) and In re Hoffmann-La Roche, 587 F.3d 1333 (Fed. [read post]
19 Aug 2013, 11:47 am by Seyfarth Shaw LLP
  In every collective action, it is important to stress at the outset that the Court has discretion under Hoffmann-La Roche to refuse to authorize the sending of notice, and that heightened scrutiny of the evidence is appropriate when the factual record demonstrates that individual issues will prevent the case from ever being tried as a collective action. [read post]
3 May 2013, 1:08 pm by Mark Zamora
The cancer-treatment drug Avastin has been linked to 52 cases of flesh-eating disease worldwide, including one that resulted in death in Canada.Health Canada issued a warning in conjunction with the drug's manufacturer, Hoffmann-La Roche Ltd., echoing an earlier one from the U.S. [read post]
23 Apr 2013, 3:17 am by Andrew Trask
The Court immediately rejected any attempt to use Rule 23 cases to support a wider ruling in Symczyk: But these cases are inapposite, both because Rule 23 actions are fundamentally different from collective actions under the FLSA, see Hoffmann-La Roche Inc., 493 U. [read post]
16 Mar 2013, 2:13 pm by admin
 This case, which resulted in European and Japanese companies paying a total of about $1 billion in criminal fines and more than $1 billion in civil judgments at the time, also included the largest cartel fine to date in Canada against a single defendant – Hoffmann-La Roch Ltd., which was fined $48 million. [read post]
28 Feb 2013, 6:01 am
Hoffmann-La Roche Holding AG engaged in biotechnology research. [read post]